Results 191 to 200 of about 59,772 (269)

Prolonged Vancomycin‐Induced Linear IgA Disease in a Patient With Renal Failure

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT A 64‐year‐old man with pneumococcal septic shock and subsequent renal failure underwent treatments with antibiotics including intravenous vancomycin (VCM). Blistering skin lesions appeared 10 days after the initiation of VCM. When the patient was transferred to us 5 months later, blisters with erythema were still observed on the abdomen and ...
Kaori Takezawa   +5 more
wiley   +1 more source

Sensitive Skin in Thais: Prevalence, Clinical Characteristics, and Diagnostic Cutoff Scores. [PDF]

open access: yesJ Cosmet Dermatol
Chaweekulrat P   +5 more
europepmc   +1 more source

Doxycycline, an antibiotic or an anti-inflammatory agent? The Most Common uses in dermatology

open access: gold, 2020
FJ Navarro‐Triviño   +2 more
openalex   +1 more source

Efficacy of Calcipotriol/Betamethasone Ointment in Facial Discoid Dermatosis

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Facial Discoid Dermatosis (FDD) is a rare chronic skin condition characterised by persistent, annular erythematous and desquamative papules on the face. Its aetiology is unclear, making differential diagnosis challenging. Key clinical features include pink‐orange, minimally scaling lesions limited to the face, sudden onset with long‐term ...
Alberto Murtas   +4 more
wiley   +1 more source

Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor [PDF]

open access: green, 2016
Viswanath Reddy Belum   +10 more
openalex   +1 more source

A Case of Anti‐TNFα Therapies Induced Lupus Panniculitis Successfully Improved With a JAK Inhibitor (Baricitinib)

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Lupus erythematosus panniculitis (LEP) is a rare variant of cutaneous lupus erythematosus (1%–3% of CLE). There are two case reports to date in the literature of LEP potentially triggered by anti‐TNF‐α therapies. Clinically, it is characterised by tender, erythematous subcutaneous indurated nodules or plaques on fatty body areas.
Cristina Grechin   +4 more
wiley   +1 more source

The Systemic Immune‐Inflammation Index and Its Association With Biologic Therapy Switching and Response in Psoriasis

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Biologic therapies have revolutionised psoriasis treatment by targeting immune pathways. Despite these advances, some patients experience suboptimal outcomes, necessitating frequent therapeutic switches. The systemic immune‐inflammation index (SII) is a novel biomarker for systemic inflammation.
Gregg Murray   +7 more
wiley   +1 more source

Risankizumab in Oncologic Patients With Psoriasis: A Case Series

open access: yes
JEADV Clinical Practice, EarlyView.
Michela Magnano   +19 more
wiley   +1 more source

Dermatomyositis-like Eruption Induced by Hydroxyurea-Case Report and Literature Review. [PDF]

open access: yesJ Clin Med
Stoica LE   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy